NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

• DOI: 10.6004/jnccn.2017.0003
• Publication Date: 2017-04-14T16:08:52Z
• Authors: Mary B. Daly; Robert Pilarski; Michael Berry; Saundra S. Buys; Meagan Farmer; Susan Friedman; Judy E. Garber; Noah D. Kauff; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K. Litton; Lisa Madlensky; Sofia D. Merajver; Kenneth Offit; Tuya Pal; Gwen Reiser; Kristen Mahoney S...; Elizabeth Swisher; Shaveta Vinayak; Nicoleta C. Voian; Jeffrey N. Weitzel; Myra J. Wick; Georgia L. Wiesner; Mary Dwyer; Susan Darlow
• Keywords: Clinical Practice; Lynch Syndrome

The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations genetic testing counseling hereditary cancer syndromes risk management patients who are diagnosed with a syndrome. focus on associated an increased of breast and/or ovarian cancer. panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data publications abstracts, reevaluate update recommendations. Insights summarize the panel's discussion most recent regarding carriers moderately penetrant mutations